Atlas Trials

Ticagrelor Single Antiplatelet Therapy in Patients With High Risk of Bleeding After DCB for Coronary Small Vessel Disease

Clinical trial NCT06088433 · UNKNOWN

Trial details

NCT number
NCT06088433
Sponsor
Fu Wai Hospital, Beijing, China
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Coronary Heart Disease
Start date
2023-11-15
Primary completion
2024-11-30
Enrollment
292

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.